Fig. 4
System organ class-based analysis of adverse event proportions in GLP-1 receptor agonist and metformin combination therapy.
Fig. 4 | Scientific Reports
System organ class-based analysis of adverse event proportions in GLP-1 receptor agonist and metformin combination therapy.
